Colgate-Palmolive (CL) shares have seen minor gains over the past week, adding around 4%. Investors looking at the stock might notice that while the short-term moves are modest, there is some curiosity about its recent performance.
See our latest analysis for Colgate-Palmolive.
Colgate-Palmolive’s modest bounce this week follows a year marked by some headwinds, with a 1-year total shareholder return of -12.7% and the share price still down over 10% year-to-date. While this recent uptick hints at stabilization, momentum has yet to fully turn in the company’s favor.
If you’re curious to see what else investors are discovering, now might be the perfect moment to broaden your search and uncover fast growing stocks with high insider ownership
Given these numbers, the key question is whether Colgate-Palmolive’s current valuation reflects underlying growth potential, or if the market is already pricing in any possible upside. This could leave little room for a buying opportunity.
Colgate-Palmolive’s most widely followed valuation narrative puts its fair value at $87.26, which is moderately above the last close of $80.93. This view highlights a spread between what analysts consider justified by the company’s future growth and the current market price.
Expansion and premiumization of core oral care lines like Colgate Total, coupled with the roll-out of complementary products across 75 markets, are set to capture increased value from emerging middle-class consumers and rising health/hygiene awareness globally. This supports top-line organic sales acceleration and improved pricing power.
Wondering what fuels this bullish viewpoint? Find out which ambitious growth targets and internal assumptions create this higher price target. The story behind the fair value may surprise even long-time investors. Explore how this narrative projects Colgate-Palmolive’s next chapter.
Result: Fair Value of $87.26 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, persistent consumer caution in key markets and ongoing pressures from rising input costs could easily disrupt the expected recovery in sales and margins.
Find out about the key risks to this Colgate-Palmolive narrative.
If you have a different perspective on Colgate-Palmolive or would rather dig into the numbers yourself, you can shape your own view in just a few minutes. Do it your way
A great starting point for your Colgate-Palmolive research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
